10-Q Filing

TRANSMEDICS GROUP, INC. CIK: 1756262 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0000950170-23-061218`
Period End Date	20230930
Filing Date	20231108
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	tmdx-20230930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 75 Cash Flow Statement 80 Stockholders Equity 56 Comprehensive Income 33

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash	`Cash`	$201.18M	USD	Point-in-time
Cash	`Cash`	$427.11M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$60.65M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$27.61M	USD	Point-in-time
Inventory	`InventoryNet`	$39.37M	USD	Point-in-time
Common Stock, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Inventory	`InventoryNet`	$20.61M	USD	Point-in-time
Common Stock, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$9.60M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.90M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	32.64M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$536.72M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	32.14M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$252.29M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$131.00M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	32.64M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	32.14M	shares	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$19.22M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$5.13M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$6.86M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Goodwill	`Goodwill`	$11.67M	USD	Point-in-time
Acquired intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$2.40M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$60.00K	USD	Point-in-time
Total assets	`Assets`	$689.23M	USD	Point-in-time
Total assets	`Assets`	$277.15M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.34M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$12.84M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$31.65M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$18.64M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$241.00K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$2.63M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.44M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.99M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$23.66M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$49.10M	USD	Point-in-time
Convertible senior notes, net	`ConvertibleDebtNoncurrent`	$446.45M	USD	Point-in-time
Long-term debt, net	`OtherLongTermDebtNoncurrent`	$58.99M	USD	Point-in-time
Long-term debt, net	`OtherLongTermDebtNoncurrent`	$58.70M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$7.42M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$8.23M	USD	Point-in-time
Total liabilities	`Liabilities`	$562.77M	USD	Point-in-time
Total liabilities	`Liabilities`	$89.77M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 32,642,130 shares and 32,141,368 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$634.46M	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 32,642,130 shares and 32,141,368 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$666.28M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-262.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-225.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-478.68M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-507.74M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$126.46M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$67.85M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$187.38M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$145.21M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$187.86M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$192.62M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$59.91M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$50.92M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$277.15M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$689.23M	USD	Point-in-time

Income Statement 75 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`Revenues`	$66.43M	USD	1 Quarter
Total revenue	`Revenues`	$160.45M	USD	3 Qtrs
Total revenue	`Revenues`	$62.08M	USD	3 Qtrs
Total revenue	`Revenues`	$25.68M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$17.52M	USD	3 Qtrs
Total cost of revenue	`CostOfRevenue`	$25.77M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$54.28M	USD	3 Qtrs
Total cost of revenue	`CostOfRevenue`	$7.57M	USD	1 Quarter
Gross profit	`GrossProfit`	$44.57M	USD	3 Qtrs
Gross profit	`GrossProfit`	$106.17M	USD	3 Qtrs
Gross profit	`GrossProfit`	$40.66M	USD	1 Quarter
Gross profit	`GrossProfit`	$18.11M	USD	1 Quarter
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$25.29M	USD	3 Qtrs
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$6.81M	USD	1 Quarter
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$11.13M	USD	1 Quarter
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$21.06M	USD	3 Qtrs
Acquired in-process research and development expenses	`AcquiredInProcessResearchAndDevelopmentExpenses`	$27.21M	USD	3 Qtrs
Acquired in-process research and development expenses	`AcquiredInProcessResearchAndDevelopmentExpenses`	$27.21M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$16.85M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$48.17M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$30.65M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$84.99M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$23.66M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$137.50M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$69.23M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$69.00M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-28.34M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-31.33M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-24.66M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-5.54M	USD	1 Quarter
Interest expense	`InterestExpense`	$7.19M	USD	3 Qtrs
Interest expense	`InterestExpense`	$3.59M	USD	1 Quarter
Interest expense	`InterestExpense`	$787.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$2.72M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$7.98M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-1.08M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-2.09M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$5.00M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$-1.86M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$-4.81M	USD	3 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$796.00K	USD	3 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$1.41M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-7.41M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-29.46M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-26.93M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-30.53M	USD	3 Qtrs
(Provision) benefit for income taxes	`CurrentIncomeTaxExpenseBenefit`	$-1.48M	USD	3 Qtrs
(Provision) benefit for income taxes	`CurrentIncomeTaxExpenseBenefit`	$47.00K	USD	3 Qtrs
(Provision) benefit for income taxes	`CurrentIncomeTaxExpenseBenefit`	$-1.51M	USD	1 Quarter
(Provision) benefit for income taxes	`CurrentIncomeTaxExpenseBenefit`	$19.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.52M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-29.06M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.64M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-36.20M	USD	Annual
Net loss	`NetIncomeLoss`	$-29.51M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.00M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-25.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.43M	USD	1 Quarter
Net loss per share attributable to common stockholders, basic	`EarningsPerShareBasic`	$-0.89	USD	3 Qtrs
Net loss per share attributable to common stockholders, basic	`EarningsPerShareBasic`	$-0.78	USD	1 Quarter
Net loss per share attributable to common stockholders, basic	`EarningsPerShareBasic`	$-1.03	USD	3 Qtrs
Net loss per share attributable to common stockholders, basic	`EarningsPerShareBasic`	$-0.25	USD	1 Quarter
Net loss per share attributable to common stockholders, diluted	`EarningsPerShareDiluted`	$-1.03	USD	3 Qtrs
Net loss per share attributable to common stockholders, diluted	`EarningsPerShareDiluted`	$-0.25	USD	1 Quarter
Net loss per share attributable to common stockholders, diluted	`EarningsPerShareDiluted`	$-0.78	USD	1 Quarter
Net loss per share attributable to common stockholders, diluted	`EarningsPerShareDiluted`	$-0.89	USD	3 Qtrs
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	32.61M	shares	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	28.73M	shares	3 Qtrs
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	32.47M	shares	3 Qtrs
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	30.23M	shares	1 Quarter
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	28.73M	shares	3 Qtrs
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	32.47M	shares	3 Qtrs
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.23M	shares	1 Quarter
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	32.61M	shares	1 Quarter

Cash Flow Statement 80 line items

Line Item	Tag	Value	Unit	Period
Convertible senior notes, issuance costs paid	`PaymentsOfDebtIssuanceCosts`	$14.62M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-29.51M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-29.06M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$4.57M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$2.19M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$7.33M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$14.07M	USD	3 Qtrs
Acquired in-process research and development expenses	`AcquiredInProcessResearchAndDevelopmentExpenses`	$27.21M	USD	3 Qtrs
Acquired in-process research and development expenses	`AcquiredInProcessResearchAndDevelopmentExpenses`	$27.21M	USD	1 Quarter
Deferred taxes	`DeferredIncomeTaxExpenseBenefit`	$-1.54M	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-575.00K	USD	3 Qtrs
Loss on sale of marketable securities	`LossOnSaleOfInvestments`	$107.00K	USD	3 Qtrs
Non-cash interest expense and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$1.36M	USD	3 Qtrs
Non-cash interest expense and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$309.00K	USD	3 Qtrs
Non-cash lease expense	`NonCashLeaseExpense`	$532.00K	USD	3 Qtrs
Non-cash lease expense	`NonCashLeaseExpense`	$728.00K	USD	3 Qtrs
Net amortization of premiums on marketable securities	`AmortizationOfDebtDiscountPremium`	$381.00K	USD	3 Qtrs
Unrealized foreign currency transaction losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-118.00K	USD	3 Qtrs
Unrealized foreign currency transaction losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-1.73M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$31.00M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$16.29M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$21.03M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$6.09M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.17M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$98.00K	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$54.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-3.53M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$6.54M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$9.26M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-8.00K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$765.00K	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$590.00K	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.10M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-41.78M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-21.33M	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$9.14M	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$110.03M	USD	3 Qtrs
Purchase of business, net of cash acquired	`PaymentsToAcquireBusinessesGross`	$14.89M	USD	3 Qtrs
Purchase of in-process research and development assets	`PaymentsToAcquireInProcessResearchAndDevelopment`	$27.21M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$10.50M	USD	3 Qtrs
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$76.92M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-152.13M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$57.28M	USD	3 Qtrs
Proceeds from issuance of convertible senior notes, net of issuance costs paid of $14,620	`ProceedsFromConvertibleDebt`	$445.38M	USD	3 Qtrs
Purchases of capped calls related to convertible senior notes	`PaymentsForDerivativeInstrumentFinancingActivities`	$52.07M	USD	3 Qtrs
Proceeds from issuance of long-term debt, net of issuance costs and issuance costs paid	`ProceedsFromIssuanceOfLongTermDebt`	$58.51M	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$36.05M	USD	3 Qtrs
Proceeds from issuance of common stock in public offering, net of underwriting discounts and commissions	`ProceedsFromIssuanceOfCommonStockInInitialPublicOfferingNetOfUnderwritingDiscountsAndCommissions`	$140.01M	USD	3 Qtrs
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$5.23M	USD	3 Qtrs
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$1.88M	USD	3 Qtrs
Proceeds from issuance of common stock in connection with employee stock purchase plan	`ProceedsFromStockPlans`	$955.00K	USD	3 Qtrs
Proceeds from issuance of common stock in connection with employee stock purchase plan	`ProceedsFromStockPlans`	$509.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$399.49M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$164.86M	USD	3 Qtrs
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-1.48M	USD	3 Qtrs
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-99.00K	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$225.93M	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$178.88M	USD	3 Qtrs
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.96M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$201.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$427.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.08M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.96M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$201.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$427.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.08M	USD	Point-in-time
Transfers of inventory to property, plant and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$2.06M	USD	3 Qtrs
Transfers of inventory to property, plant and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$2.22M	USD	3 Qtrs
Purchases of property, plant and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$926.00K	USD	3 Qtrs
Purchases of property, plant and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$1.72M	USD	3 Qtrs
Operating lease liabilities arising from obtaining right-of-use assets	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$2.17M	USD	3 Qtrs
Offering costs included in accounts payable and accrued expenses	`OfferingCostIncludedInAccountsPayableAndAccruedExpenses`	$160.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$204.46M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$427.11M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.96M	USD	Point-in-time
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$201.68M	USD	Point-in-time
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$427.61M	USD	Point-in-time
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.08M	USD	Point-in-time

Stockholders Equity 56 line items

Line Item	Tag	Value	Unit	Period
Discounts and issuance costs	`DiscountsAndIssuanceCosts`	$676.00K	USD	1 Quarter
Balance	`StockholdersEquity`	$126.46M	USD	Point-in-time
Balance	`StockholdersEquity`	$67.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$187.38M	USD	Point-in-time
Balance	`StockholdersEquity`	$145.21M	USD	Point-in-time
Balance	`StockholdersEquity`	$187.86M	USD	Point-in-time
Balance	`StockholdersEquity`	$192.62M	USD	Point-in-time
Balance	`StockholdersEquity`	$59.91M	USD	Point-in-time
Balance	`StockholdersEquity`	$50.92M	USD	Point-in-time
Issuance of common stock in public offering, net of discounts and issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$139.85M	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$202.00K	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.57M	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.44M	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$952.00K	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$705.00K	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$237.00K	USD	1 Quarter
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$306.00K	USD	1 Quarter
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$203.00K	USD	1 Quarter
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$384.00K	USD	1 Quarter
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$571.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$2.32M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$2.31M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$3.92M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$4.96M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$5.19M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$2.70M	USD	1 Quarter
Purchases of capped calls related to convertible senior notes	`PurchasesOfCappedCallsRelatedToConvertibleSeniorNotes`	$-52.07M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-30.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-41.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-42.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-24.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-95.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-37.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$7.00K	USD	1 Quarter
Unrealized losses on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-73.00K	USD	1 Quarter
Unrealized losses on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$36.00K	USD	3 Qtrs
Unrealized losses on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$9.00K	USD	1 Quarter
Unrealized losses on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$100.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.52M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-29.06M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.64M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-36.20M	USD	Annual
Net loss	`NetIncomeLoss`	$-29.51M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.00M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-25.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.43M	USD	1 Quarter
Balance	`StockholdersEquity`	$126.46M	USD	Point-in-time
Balance	`StockholdersEquity`	$67.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$187.38M	USD	Point-in-time
Balance	`StockholdersEquity`	$145.21M	USD	Point-in-time
Balance	`StockholdersEquity`	$187.86M	USD	Point-in-time
Balance	`StockholdersEquity`	$192.62M	USD	Point-in-time
Balance	`StockholdersEquity`	$59.91M	USD	Point-in-time
Balance	`StockholdersEquity`	$50.92M	USD	Point-in-time

Comprehensive Income 33 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-11.52M	USD	1 Quarter
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	1 Quarter
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	1 Quarter
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-10.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-29.06M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.64M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-36.20M	USD	Annual
Net loss	`NetIncomeLoss`	$-29.51M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-25.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.43M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-30.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-41.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-42.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-24.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-95.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-37.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$7.00K	USD	1 Quarter
Unrealized gains on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-73.00K	USD	1 Quarter
Unrealized gains on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$36.00K	USD	3 Qtrs
Unrealized gains on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$9.00K	USD	1 Quarter
Unrealized gains on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$100.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-42.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-37.00K	USD	3 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$59.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-59.00K	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-25.46M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-29.10M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-29.57M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-7.37M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.